Association of Natriuretic Peptides With Cardiovascular Prognosis in Heart Failure With Preserved Ejection Fraction: Secondary Analysis of the TOPCAT Randomized Clinical Trial

IMPORTANCE: Contemporary clinical trials of heart failure with preserved ejection fraction (HFpEF) apply natriuretic peptide (NP) thresholds to identify patients who are more likely to have the disease of interest and to enrich the baseline risk of the enrolled cohort. OBJECTIVE: To determine whethe...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:JAMA Cardiol
Hlavní autoři: Myhre, Peder Langeland, Vaduganathan, Muthiah, Claggett, Brian L., Anand, Inder S., Sweitzer, Nancy K., Fang, James C., O'Meara, Eileen, Shah, Sanjiv J., Desai, Akshay S., Lewis, Eldrin F., Rouleau, Jean, Pitt, Bertram, Pfeffer, Marc A., Solomon, Scott D.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Medical Association 2018
Témata:
Brief Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233827/
https://ncbi.nlm.nih.gov/pubmed/30140899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2018.2568
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky